AGREEMENT AND PLAN OF MERGER among Cellular Biomedicine Group, Inc., CBMG Holdings and CBMG Merger Sub Inc. Dated as of August 11, 2020Merger Agreement • August 12th, 2020 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances) • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of August 11, 2020, is entered into by and among Cellular Biomedicine Group, Inc., a Delaware corporation (the “Company”), CBMG Holdings, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“Parent”), and CBMG Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”). All capitalized term used in this Agreement shall have the meaning ascribed to them in Annex A hereto.
BRIDGE LOAN AGREEMENTBridge Loan Agreement • August 12th, 2020 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances) • Hong Kong
This BRIDGE LOAN AGREEMENT (this “Agreement”) is made and entered into on August 11, 2020 (the “Effective Date”), by and among the following parties:
Amendment LetterLoan Agreement • August 12th, 2020 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances)
